Effects of reducing and oxidizing agents on the adenylate cyclase activity in adipocyte plasma membranes.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000273:Adipose Tissue / Q000201:enzymology* / Q000648:ultrastructure; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D002462:Cell Membrane / Q000201:enzymology; D004789:Enzyme Activation / Q000187:drug effects; D004822:Epididymis; D005292:Ferricyanides / Q000494:pharmacology; D008297:Male; D009243:NAD / Q000494:pharmacology*; D009249:NADP / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010084:Oxidation-Reduction; D051381:Rats
D005292:Ferricyanides; D009243:NAD; D009249:NADP; D000324:Adrenocorticotropic Hormone; D000262:Adenylyl Cyclases; D009638:Norepinephrine